Our next webinar with Molecular Devices : A physiologically-relevant 3D ECM for in vitro oncology research and intelligent high-content imaging of 3D models

We are very happy to invite you to our next webinar about 3D cellular cancer models and our BIOMIMESYS® Oncology matrix which allows cancer cells to be cultured in a tumor-like environment, with the possibility to tune the composition and stiffness of the matrix. We will also share our best practices in 3D imaging with our automated confocal microscopes made by Molecular Devices.

This webinar will be presented by Elodie Vandenhaute (study director at HCS Pharma) and Guillaume Frugier (senior imaging applications scientist at Molecular Devices).

To register, please follow this link : https://www.labroots.com/webinar/physiologically-relevant-3d-ecm-vitro-oncology-research-intelligent-high-content-imaging-3d-models